Frank Brown

1.3k total citations
30 papers, 1.0k citations indexed

About

Frank Brown is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Frank Brown has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 6 papers in Organic Chemistry. Recurrent topics in Frank Brown's work include Receptor Mechanisms and Signaling (10 papers), Analytical Chemistry and Chromatography (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). Frank Brown is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Analytical Chemistry and Chromatography (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). Frank Brown collaborates with scholars based in United Kingdom, United States and Italy. Frank Brown's co-authors include Michael Clark, Graham J. Riley, Barry S. Orlek, Harry J. Wadsworth, Robert E. Ireland, Derek N. Middlemiss, K.H. Jennings, Michael S. Hadley, William M. Draper and Gareth W. Roberts and has published in prestigious journals such as Analytical Chemistry, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Frank Brown

30 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Brown United Kingdom 15 399 357 198 187 145 30 1.0k
Romano Di Fabio Italy 24 609 1.5× 900 2.5× 86 0.4× 336 1.8× 117 0.8× 104 1.7k
Shigenori Ohkawa Japan 18 295 0.7× 337 0.9× 190 1.0× 144 0.8× 307 2.1× 31 1.3k
Emmanuel Pinard Switzerland 20 545 1.4× 385 1.1× 50 0.3× 321 1.7× 168 1.2× 44 1.3k
Darius P. Zlotos Germany 19 610 1.5× 354 1.0× 104 0.5× 265 1.4× 119 0.8× 66 1.4k
Michael S. Hadley United Kingdom 16 472 1.2× 494 1.4× 28 0.1× 277 1.5× 118 0.8× 55 1.0k
Mohammad R. Marzabadi United States 16 380 1.0× 310 0.9× 105 0.5× 249 1.3× 109 0.8× 24 1.1k
Nigel Austin United Kingdom 14 329 0.8× 165 0.5× 45 0.2× 253 1.4× 134 0.9× 24 727
Annalida Bedini Italy 27 555 1.4× 707 2.0× 158 0.8× 293 1.6× 256 1.8× 84 1.9k
Cor J. Grol Netherlands 18 446 1.1× 219 0.6× 66 0.3× 471 2.5× 93 0.6× 47 929
Jean Schwartz France 21 605 1.5× 158 0.4× 192 1.0× 544 2.9× 46 0.3× 48 1.3k

Countries citing papers authored by Frank Brown

Since Specialization
Citations

This map shows the geographic impact of Frank Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Brown more than expected).

Fields of papers citing papers by Frank Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Brown. The network helps show where Frank Brown may publish in the future.

Co-authorship network of co-authors of Frank Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Brown. A scholar is included among the top collaborators of Frank Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Brown. Frank Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wood, Martyn, Michael Ho, Jeannette M. Watson, et al.. (1999). Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry. British Journal of Pharmacology. 126(7). 1620–1624. 51 indexed citations
2.
Smart, D, Jeffrey C. Jerman, Stephen Brough, et al.. (1999). Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell‐line using FLIPR. British Journal of Pharmacology. 128(1). 1–3. 150 indexed citations
3.
Udodong, Uko E., et al.. (1998). Studies on the phosphorylation of LY303366. Tetrahedron Letters. 39(34). 6115–6118. 4 indexed citations
4.
Cutler, P. H., Frank Brown, Patrick Camilleri, et al.. (1997). The recognition of haemoglobin by antibodies raised for the immunoassay of β‐amyloid. FEBS Letters. 412(2). 341–345. 2 indexed citations
6.
Barton, A.J.L., Eric Karran, Frank Brown, et al.. (1996). Alteration in Brain Presenilin 1 mRNA Expression in Early Onset Familial Alzheimer's Disease. PubMed. 5(3). 213–218. 13 indexed citations
7.
Howlett, David, K.H. Jennings, David C. Lee, et al.. (1995). Aggregation State and Neurotoxic Properties of Alzheimer Beta-Amyloid Peptide. PubMed. 4(1). 23–32. 170 indexed citations
8.
Brown, Frank, Martyn C. Davies, K.H. Jennings, et al.. (1995). Scanning tunnelling microscopy studies of β‐amyloid fibril structure and assembly. FEBS Letters. 371(1). 25–28. 15 indexed citations
9.
Brown, Frank, et al.. (1995). Evaluation and Application of Supercritical Fluid Chromatography with Electrolytic Conductivity Detection. Analytical Letters. 28(4). 703–729. 1 indexed citations
10.
Stone, Trevor W., et al.. (1993). Characterization of the adenosine receptors of the rat superior cervical ganglion. British Journal of Pharmacology. 110(2). 854–860. 11 indexed citations
11.
Bowen, Wayne P., et al.. (1993). Evidence for more than one binding site in cloned D2 and D3 dopamine receptors. Biochemical Society Transactions. 21(1). 56S–56S. 1 indexed citations
12.
Wadsworth, Harry J., S. M. Jenkins, Barry S. Orlek, et al.. (1992). Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives. Journal of Medicinal Chemistry. 35(7). 1280–1290. 68 indexed citations
13.
Bromidge, Steven M., Frank Brown, Frederick Cassidy, et al.. (1992). A novel and selective class of azabicyclic muscarinic agonists incorporating an N-methoxy imidoyl halide or nitrile functionality. Bioorganic & Medicinal Chemistry Letters. 2(8). 791–796. 16 indexed citations
14.
Orlek, Barry S., Frank E. Blaney, Frank Brown, et al.. (1991). Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor. Journal of Medicinal Chemistry. 34(9). 2726–2735. 171 indexed citations
15.
Draper, William M., et al.. (1989). Thermospray mass spectrometry and tandem mass spectrometry of polar, urinary metabolites and metabolic conjugates. Journal of Mass Spectrometry. 18(9). 767–774. 21 indexed citations
16.
Brown, Frank & William M. Draper. (1989). Separation of phenols and their glucuronide and sulfate conjugates by anion-exchange liquid chromatography. Journal of Chromatography A. 479(2). 441–444. 5 indexed citations
17.
Brown, Frank, William Campbell, Michael Clark, et al.. (1988). The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide. Psychopharmacology. 94(3). 350–8. 5 indexed citations
19.
Ireland, Robert E. & Frank Brown. (1980). Macrocyclic lactone formation through sulfide contraction. Synthesis of (.+-.)-diplodialide A. The Journal of Organic Chemistry. 45(10). 1868–1880. 48 indexed citations
20.
Feuer, Henry & Frank Brown. (1970). Chemistry of hydrazides. X. The reduction of cyclic and acyclic hydrazides with diborane. The Journal of Organic Chemistry. 35(5). 1468–1471. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026